Long COVID‑19 and pregnancy: A systematic review

Vasiliki Epameinondas Georgakopoulou1, Chrysoula Taskou2, Demetrios A Spandidos3

  • 1Department of Pathophysiology, Laiko General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.

Biomedical Reports
|December 3, 2024
PubMed

Insights

Long COVID-19 significantly affects pregnant women, with symptoms like fatigue being common. Risk factors include severe acute infection and non-vaccination, impacting maternal and neonatal health.

Area of Science:

  • Obstetrics and Gynecology
  • Infectious Diseases
  • Public Health

Background:

  • Post-acute sequelae of SARS-CoV-2 infection, or Long COVID-19, is a growing concern in pregnant populations.
  • Understanding its prevalence, risk factors, and outcomes is crucial for maternal health.

Purpose of the Study:

  • To systematically review and synthesize current evidence on Long COVID-19 in pregnant women.
  • To identify prevalence rates, associated risk factors, and clinical outcomes.

Main Methods:

  • Systematic literature search in PubMed, Scopus, and Google Scholar (Jan 2020 - Oct 2024).
  • Inclusion of studies on pregnant/postpartum women with COVID-19 followed for ≥4 weeks.
  • Narrative synthesis of data from 13 studies (13,729 participants) due to heterogeneity.

Main Results:

  • Prevalence of Long COVID-19 in pregnant women ranged widely from 9.3% to 93%.
  • Most common symptoms include fatigue, cognitive dysfunction, respiratory issues, and psychological disturbances.
  • Key risk factors identified: severe acute COVID-19, obesity, pre-existing mental health conditions, and non-vaccination.

Conclusions:

  • Long COVID-19 is prevalent in pregnant women, presenting diverse symptoms and impacting maternal/neonatal outcomes (e.g., preterm birth).
  • Severe acute infection and comorbidities increase risk and severity.
  • Targeted follow-up and standardized definitions are needed for effective management and research.